Beyond Medical Technologies Inc. Announces Management Changes and New Appointment of Daniel Liu as Chief Executive Officer and Director
Rhea-AI Summary
Beyond Medical Technologies (CSE: DOCT, OTC: DOCKF) has announced a significant leadership change with the appointment of Daniel Liu as Chief Executive Officer and director, effective January 30, 2025. Liu succeeds Kal Malhi, who has stepped down from his positions as CEO and director to pursue other ventures. While departing from his executive roles, Malhi will remain available as a consultant to the company as needed.
Positive
- None.
Negative
- None.
News Market Reaction 1 Alert
On the day this news was published, DOCKF declined 18.18%, reflecting a significant negative market reaction.
Data tracked by StockTitan Argus on the day of publication.
Vancouver, British Columbia--(Newsfile Corp. - February 3, 2025) - Beyond Medical Technologies Inc. (CSE: DOCT) (FSE: 7FM) (OTC Pink: DOCKF) ("Beyond Medical" or the "Company") is pleased to announce that it has appointed Daniel Liu as Chief Executive Officer and as a director of the Company. Mr. Liu replaces Kal Malhi in these roles, following Mr. Malhi's resignation as Chief Executive Officer and as a director, effective January 30, 2025.
Mr Malhi leaves Beyond Medical to pursue other ventures but will remain available to consult for the Company as required. The Company would like to thank Mr. Malhi for his service and wishes him the best in his future endeavors.
On behalf of the Board of Directors
"Daniel Liu" Chief Executive Officer
Email: danzliu94@gmail.com
https://beyond-md.ca/
Neither the Canadian Securities Exchange nor its Regulation Services Provider has reviewed or accepts responsibility for the accuracy or adequacy of this release.
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/239500